BACKGROUND: The incidence of cytomegalovirus (CMV) syndrome/disease after adult
solid organ transplantation in the era effective antiviral therapy has not been fully assessed …

Cytomegalovirus infection (CMV) in solid organ transplant recipients is a major clinical
problem. The aim of this study was to evaluate the incidence of CMV infection and its …

Late‐onset cytomegalovirus (CMV) disease is a significant problem in D+/R− solid organ
transplant (SOT) patients who receive antiviral prophylaxis. We assessed the clinical utility of …

BACKGROUND: Late-onset CMV disease is being increasingly recognized as a significant
post-transplantation complication. OBJECTIVES: To discern the impact of antiviral …

The natural history of cytomegalovirus (CMV) disease associated with solid organ
transplantation has been modified as a result of the widespread use of antiviral prophylaxis …

Background: Infection with cytomegalovirus (CMV) remains a potentially serious
complication in transplant patients. In this study we explored the risk factors for CMV …

Background Cytomegalovirus (CMV) disease typically occurs during the first year after solid
organ transplantation, after cessation of antiviral prophylaxis. CMV occurring after the first …

INTRODUCTION: Despite recent advances in prevention and treatment, cytomegalovirus
(CMV) is still a major complication in transplant patients. This study sought to analyze the …

AA Boudreault, H. Xie, RM Rakita, JD Scott, CL Davis, M. Boeckh, AP Limaye. Risk factors
for late‐onset cytomegalovirus disease in donor seropositive/recipient seronegative kidney …

The introduction and combination of more-potent immunosuppressive regimens, and the
increased transplantation of organs into more severely ill patients, have again placed …